AstraZeneca PLC Stock Forecast - 20 Period Moving Average

AZN Stock  USD 66.45  0.49  0.73%   
The 20 Period Moving Average forecasted value of AstraZeneca PLC ADR on the next trading day is expected to be 66.26 with a mean absolute deviation of 3.75 and the sum of the absolute errors of 153.88. AstraZeneca Stock Forecast is based on your current time horizon. Although AstraZeneca PLC's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of AstraZeneca PLC's systematic risk associated with finding meaningful patterns of AstraZeneca PLC fundamentals over time.
  
At this time, AstraZeneca PLC's Inventory Turnover is very stable compared to the past year. As of the 13th of December 2024, Asset Turnover is likely to grow to 0.79, while Payables Turnover is likely to drop 1.70. . As of the 13th of December 2024, Net Income Applicable To Common Shares is likely to grow to about 3.2 B, while Common Stock Shares Outstanding is likely to drop about 2.9 B.
A commonly used 20-period moving average forecast model for AstraZeneca PLC ADR is based on a synthetically constructed AstraZeneca PLCdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

AstraZeneca PLC 20 Period Moving Average Price Forecast For the 14th of December 2024

Given 90 days horizon, the 20 Period Moving Average forecasted value of AstraZeneca PLC ADR on the next trading day is expected to be 66.26 with a mean absolute deviation of 3.75, mean absolute percentage error of 24.39, and the sum of the absolute errors of 153.88.
Please note that although there have been many attempts to predict AstraZeneca Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that AstraZeneca PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

AstraZeneca PLC Stock Forecast Pattern

Backtest AstraZeneca PLCAstraZeneca PLC Price PredictionBuy or Sell Advice 

AstraZeneca PLC Forecasted Value

In the context of forecasting AstraZeneca PLC's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. AstraZeneca PLC's downside and upside margins for the forecasting period are 64.77 and 67.75, respectively. We have considered AstraZeneca PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
66.45
66.26
Expected Value
67.75
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of AstraZeneca PLC stock data series using in forecasting. Note that when a statistical model is used to represent AstraZeneca PLC stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria84.5472
BiasArithmetic mean of the errors 2.7475
MADMean absolute deviation3.7531
MAPEMean absolute percentage error0.0565
SAESum of the absolute errors153.8785
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. AstraZeneca PLC ADR 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for AstraZeneca PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
64.9566.4467.93
Details
Intrinsic
Valuation
LowRealHigh
59.8170.8072.29
Details
Bollinger
Band Projection (param)
LowMiddleHigh
59.5970.7081.81
Details
11 Analysts
Consensus
LowTargetHigh
76.1883.7192.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AstraZeneca PLC. Your research has to be compared to or analyzed against AstraZeneca PLC's peers to derive any actionable benefits. When done correctly, AstraZeneca PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AstraZeneca PLC ADR.

Other Forecasting Options for AstraZeneca PLC

For every potential investor in AstraZeneca, whether a beginner or expert, AstraZeneca PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AstraZeneca Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AstraZeneca. Basic forecasting techniques help filter out the noise by identifying AstraZeneca PLC's price trends.

AstraZeneca PLC Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AstraZeneca PLC stock to make a market-neutral strategy. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

AstraZeneca PLC ADR Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AstraZeneca PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AstraZeneca PLC's current price.

AstraZeneca PLC Market Strength Events

Market strength indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC stock market strength indicators, traders can identify AstraZeneca PLC ADR entry and exit signals to maximize returns.

AstraZeneca PLC Risk Indicators

The analysis of AstraZeneca PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AstraZeneca PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astrazeneca stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.

Moving together with AstraZeneca Stock

  0.85JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.94LLY Eli LillyPairCorr

Moving against AstraZeneca Stock

  0.86BMY Bristol Myers SquibbPairCorr
  0.84GILD Gilead SciencesPairCorr
  0.84CAH Cardinal HealthPairCorr
  0.83XAIR Beyond AirPairCorr
  0.63ESPR Esperion TherapeuticsPairCorr
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.034
Dividend Share
2.97
Earnings Share
2.08
Revenue Per Share
2.7424
Quarterly Revenue Growth
0.18
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.